This Kratom Bill Is a Fig Leaf and Everyone Knows It
Let’s stop pretending.
This bill does not protect the public. It protects lawmakers from having to say the hard thing out loud.
And the hard thing is this: kratom acts like an opioid, and people are getting hooked on it.
If you regulate around that truth instead of stating it plainly, you are not solving a problem, you are dressing it up and calling it progress.
Washington Already Answered the Question You’re Avoiding
Primary Source: Wyoming Bill Text
The full text of the introduced Wyoming bill discussed on this page is available below for independent review.
The FDA didn’t hedge. It didn’t dance. It didn’t ask permission.
It said kratom products are adulterated under federal law because they are unsafe, unapproved, and pharmacologically active in ways that cause real harm.
This bill does not change that. It cannot change that.
All it does is redefine “adulterated” for Wyoming so you can say, with a straight face, that you regulated something Washington says shouldn’t be sold at all.
That’s not courage. That’s a workaround.
Regulation That Tiptoes Is Regulation That Fails
This bill fusses over packaging. It bans candy shapes. It sets age limits. It caps alkaloid percentages.
All fine and all beside the point.
Because the people getting hurt aren’t children sneaking gummies.
They’re adults who were told this was natural, safe, regulated, better than opioids until they tried to stop taking it and found themselves shaking, sick, anxious, and trapped.
And this bill never tells them that will happen.
Not once. Not plainly. Not honestly.
“May Be Habit Forming” Is Lawyer Language, Not Public Health
If a product can cause opioid-like withdrawal, you don’t whisper that it “may be habit forming.”
That’s not a warning. That’s an evasion.
We didn’t beat tobacco by suggesting cigarettes might be habit forming. We didn’t address opioids by advising people to “consult a healthcare provider.”
We told the truth loudly because people deserved it.
This bill chooses silence instead.
The 2% Number Is a Comfort Blanket
Supporters point to a 2% cap on 7-hydroxymitragynine like it’s a shield.
It isn’t.
People don’t dose by chemistry charts. They dose by relief. They dose by effect. They dose until it works and then they dose again.
Withdrawal doesn’t care about your percentage. Dependence doesn’t read your statute.
This is paper safety for real-world harm.
What This Bill Really Does
Let’s be honest about what you’re voting for.
This bill:
- Keeps kratom on shelves
- Lets retailers say it’s “regulated”
- Avoids telling consumers the worst risk
- Shifts responsibility from sellers to users
- And gives everyone plausible deniability when things go wrong
That’s not public health. That’s political insulation.
If You Want to Protect People, Say the Damn Thing Out Loud
There is one step that would actually reduce harm. One sentence that would force honesty at the point of sale.
Put this on the front of the package:
WARNING:
This product has opioid-like effects and may cause dependence, tolerance, and opioid-like withdrawal.
Use may result in physical addiction.
If that warning scares people away, that’s not a problem. That’s the point.
Ask Yourself Why That Sentence Isn’t Here
The industry can survive testing. It can survive age limits. It can survive packaging rules.
What it can’t survive is an informed consumer.
That’s why this bill goes everywhere except the truth.
One Last Question Before You Vote
If this product can cause opioid-like withdrawal, and you knew that, and you chose not to say it plainly —
who does this bill really protect?
Because it isn’t the people walking into vape shops believing regulation means safety.
Wyoming doesn’t need a fig leaf. It needs the nerve to tell the truth.